Status: Recruiting
Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
This is a registry-based, randomized, controlled clinical trial of the effect of added high-flow oxygen therapy (using the device Lumis HFT) during one year in people with long-term oxygen therapy (LTOT) for chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).
Participants needed: 310
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Skane University HospitalUpdated: May 21, 2025Locations: 2
Eligibility criteria
Age 40 years or older [+4]
Current or previous treatment with home HFOT [+10]